共 83 条
[1]
Jain A(2013)Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects J Biomed Nanotechnol 9 891-900
[2]
Singh SK(2010)Anticytokine therapy for osteoarthritis: evidence to date Drugs Aging 27 95-115
[3]
Singh Y(2012)Nutraceuticals in the management of osteoarthritis: a critical review Drugs Aging 29 717-731
[4]
Singh S(2013)Disease-modifying osteoarthritis drugs: Expert Opin Investig Drugs 22 423-441
[5]
Malemud CJ(1986) and in vivo data on the development of DMOADs under investigation Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29 1039-1049
[6]
Ragle RL(1957)Development of criteria for the classification and reporting of osteoarthritis Ann Rheum Dis 16 494-502
[7]
Sawitzke AD(2003)Radiological assessment of osteo-arthrosis Inflamm Res 52 404-407
[8]
Davies PS(2003)The production of anti-inflammatory cytokines in whole blood by physico-chemical induction Measures of adult lower extremity function. Arthritis Rheum 49 S67-S84
[9]
Graham SM(2007)Western Ontario and Macmaster Universities Index Randomized Controlled Trials. ACS in Clinical Human Studies. Autologous conditioned serum in the treatment of orthopedic diseases. The Orthokine Therapy. Biodrugs 21 328-329
[10]
MacFarlane RJ(2009)Reinecke: Knee Osteoarthritis Osteoarthritis Cartilage 17 152-160